FCAR antibody

Catalog No. ABIN933573

Product Details anti-FCAR Antibody

Target: FCAR (Fc Fragment of IgA, Receptor For (FCAR))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This FCAR antibody is un-conjugated

Application: Flow Cytometry (FACS), Immunofluorescence (IF)

Purification: Protein A affinity chromatography

Immunogen: CD89 antibody was raised in Mouse using Soluble CD89 as the immunogen.

Clone: MIP8a

Isotype: IgG1

Application Details

Application Notes: FC: 10 µg/mL, IF: 10 µg/mL
Optimal conditions should be determined by the investigator.

Restrictions: For Research Use only

Handling

Concentration: Lot specific

Buffer: Supplied in PBS containing 0.1 % sodium azide as a preservative

Preservative: Sodium azide

Precaution of Use: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handling Advice: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Storage: -20 °C/-80 °C

Storage Comment: Store at 4 °C for up to 1 month. For long term storage, aliquot and store at -20 to -80 °C.

Target Details for FCAR

Target: FCAR (Fc Fragment of IgA, Receptor For (FCAR))

Alternative Name: CD89 (FCAR Products)

Synonyms: CD89 antibody, Fc fragment of IgA receptor antibody, Fc fragment of IgA, receptor for antibody, FCAR antibody

Background: CD89 is a receptor for the Fc region of IgA. The receptor is a transmembrane glycoprotein present on the surface of myeloid lineage cells such as neutrophils, monocytes, macrophages, and eosinophils, where it mediates immunologic responses to pathogens. It interacts with IgA-opsonized targets and triggers several immunologic defense processes, including phagocytosis, antibody-dependent cell-mediated cytotoxicity, and stimulation of the release of inflammatory mediators. Synonyms: Monoclonal CD89 antibody, Anti-CD89 antibody, CD 89 antibody, CD-89 antibody, Fc fragment of IgA receptor antibody, FCAR antibody, Cluster of Differentiation 89 antibody, CD 89 antibody.